Charmacy Pharmaceutical Co., Ltd. (2289.HK)

HKD 9.0

(0.0%)

Operating Expenses Summary of Charmacy Pharmaceutical Co., Ltd.

Charmacy Pharmaceutical Co., Ltd.'s latest annual operating expenses in 2023 was 222.18 Million CNY , up 53.35% from previous year.
Charmacy Pharmaceutical Co., Ltd.'s latest quarterly operating expenses in 2024 Q2 was 125.62 Million CNY , up 6.95% from previous quarter.
Charmacy Pharmaceutical Co., Ltd. reported a annual operating expenses of 116.08 Million CNY in annual operating expenses 2022, down -28.96% from previous year.
Charmacy Pharmaceutical Co., Ltd. reported a annual operating expenses of 163.41 Million CNY in annual operating expenses 2021, up 5.47% from previous year.
Charmacy Pharmaceutical Co., Ltd. reported a quarterly operating expenses of 89.14 Million CNY for 2023 Q2, up 152.45% from previous quarter.
Charmacy Pharmaceutical Co., Ltd. reported a quarterly operating expenses of 178.01 Million CNY for 2023 FY, up 53.35% from previous quarter.

Annual Operating Expenses Chart of Charmacy Pharmaceutical Co., Ltd. (2023 - 2013)

Historical Annual Operating Expenses of Charmacy Pharmaceutical Co., Ltd. (2023 - 2013)

Year	Operating Expenses	Operating Expenses Growth
2023	222.18 Million CNY	53.35%
2022	116.08 Million CNY	-28.96%
2021	163.41 Million CNY	5.47%
2020	154.94 Million CNY	11.63%
2019	138.8 Million CNY	-3.31%
2018	143.55 Million CNY	14.33%
2017	125.55 Million CNY	39.14%
2016	90.23 Million CNY	-12.96%
2015	103.67 Million CNY	43.19%
2014	72.4 Million CNY	24.62%
2013	58.1 Million CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	125.62 Million CNY	6.95%
2023 Q2	89.14 Million CNY	152.45%
2023 FY	178.01 Million CNY	53.35%
2023 Q4	117.45 Million CNY	31.77%
2022 FY	116.08 Million CNY	-28.96%
2022 Q4	35.31 Million CNY	-56.29%
2022 Q2	80.77 Million CNY	-4.84%
2021 FY	163.41 Million CNY	5.47%
2021 Q2	78.53 Million CNY	-12.95%
2021 Q4	84.88 Million CNY	8.09%
2020 Q4	90.21 Million CNY	39.39%
2020 Q2	64.72 Million CNY	-13.34%
2020 FY	154.94 Million CNY	11.63%
2019 Q4	74.68 Million CNY	16.47%
2019 Q2	64.11 Million CNY	-14.45%
2019 FY	138.8 Million CNY	-3.31%
2018 Q2	68.6 Million CNY	1.08%
2018 Q4	74.94 Million CNY	9.25%
2018 FY	143.55 Million CNY	14.33%
2017 Q4	67.87 Million CNY	17.67%
2017 FY	125.55 Million CNY	39.14%
2017 Q2	57.68 Million CNY	23.65%
2016 Q4	46.64 Million CNY	7.02%
2016 Q2	43.58 Million CNY	-33.27%
2016 FY	90.23 Million CNY	-12.96%
2015 Q2	38.36 Million CNY	-8.05%
2015 FY	103.67 Million CNY	43.19%
2015 Q4	65.31 Million CNY	70.28%
2014 FY	72.4 Million CNY	24.62%
2014 Q2	30.68 Million CNY	69.54%
2014 Q4	41.71 Million CNY	35.94%
2013 FY	58.1 Million CNY	0.0%
2013 Q4	18.1 Million CNY	0.0%

Peer Operating Expenses Comparison of Charmacy Pharmaceutical Co., Ltd.

Name	Operating Expenses	Operating Expenses Difference
Wanjia Group Holdings Limited	70.14 Million HKD	-216.769%
China Health Group Limited	56.52 Million HKD	-293.079%
Tai United Holdings Limited	387.97 Million HKD	42.731%